When buyers compare empty capsules from China, size, material and price usually come first. For pharmaceutical projects, another point needs to be checked early: the China CDE registration record.
This article explains how buyers can read a CDE registration number for empty capsules, and why HPMC empty capsules should be reviewed together with registration status A, product name and registered company.
In practical terms, a CDE registration number helps confirm whether an empty capsule product is listed in China's pharmaceutical excipient registration system. Status A gives buyers and quality teams a clearer public reference. It does not replace sample testing, COA review or supplier qualification, but it makes the first screening more reliable.
What a CDE registration number means
CDE refers to China's Center for Drug Evaluation. For pharmaceutical excipients, packaging materials and related items, the public registration system lets buyers check product names, registration numbers, status and registration holders.
For empty capsules, the first question is simple: is this capsule shell registered as a pharmaceutical excipient in China?
A registration number should not be read on its own. It should be checked together with the product name, registration status and company name.
| What to check | What it tells you | Why it matters |
|---|---|---|
| Product name | Whether the record is for gelatin empty capsules, HPMC empty capsules or another material | Helps avoid using documents from a different capsule product |
| CDE registration number | Whether the number points to a specific registered product | Supports supplier screening and quality document review |
| Registration status | Whether the status is A | Affects early project assessment and document planning |
| Registration holder | Whether the listed company matches the supplier documents | Matters for audits, quality agreements and batch traceability |
Once these four points line up, the basic document check is much clearer. Buyers can then move on to samples, specifications, COA documents and commercial terms.
Why status A matters
In China's excipient and packaging-material registration system, public records may show status letters such as A and I. Status A generally means that a clearer public review/use status is available under China's regulatory framework. Status I does not provide the same public reference.
For a pharmaceutical company, this is not just a letter on a webpage. It can affect registration work, supplier qualification, QA review and change-control discussions.
| Status | Practical reading | How buyers usually use it |
|---|---|---|
| A | A clearer public review/use status is available | Useful for early supplier screening, registration support and quality document review |
| I | The same public reference is not available | Should not be treated as equivalent to status A without further project review |
For overseas customers, the useful reading is practical: treat the CDE record as China-specific regulatory information, then review it together with local regulatory needs, supplier qualification and project documents.
Why HPMC empty capsules need a clearer check
HPMC empty capsules are often considered when a project needs a plant-based capsule shell, lower animal-origin concern or a better fit for certain moisture-sensitive fills. They are used in pharmaceutical, nutraceutical and OEM/ODM projects.
Still, “plant-based capsule” and “pharmaceutical HPMC empty capsule” are not the same claim. Some HPMC capsules are made for food, supplement or general wellness products. Those products can be useful in their own markets, but they do not automatically provide the excipient registration basis needed for pharmaceutical use in China.
For HPMC capsule projects, buyers should first check three simple points: the product name, the CDE registration number and whether the status is A. Once those basics are clear, the next review can cover the Certificate of Analysis (COA), specifications, sample testing, packaging and stability.
For a deeper look at batch documents, see how to read an empty capsule COA.
StellarCaps CDE status A records
Jilin Xingyuan Capsule Co., Ltd., also known as StellarCaps, has two empty capsule products with China CDE registration status A: gelatin empty capsules and hydroxypropyl methylcellulose empty capsules, commonly known as HPMC empty capsules.
| Product | CDE registration number | Status | Typical review context |
|---|---|---|---|
| Gelatin empty capsules | F20240000553 | A | Conventional oral solid dosage projects and mature capsule applications |
| Hydroxypropyl methylcellulose empty capsules (HPMC empty capsules) | F20240000554 | A | Plant-based pharmaceutical capsule projects, QA review and supplier qualification |
These records are more than company profile details. They give pharmaceutical buyers, QA teams and OEM/ODM customers a clearer starting point when they compare suppliers from China.
You can review the related page on StellarCaps certifications and CDE status A records, or continue with the product pages for gelatin empty capsules and HPMC empty capsules.
What to check after status A
Status A is important, but it does not decide the whole project.
An empty capsule still has to fit the formulation, target fill weight, filling equipment, packaging and stability plan. A moisture-sensitive powder, for example, may need a different review than a standard dry blend. A bulk empty capsule order also needs consistent separation, locking, appearance and batch documentation.
For QA review, buyers usually continue with the COA, specification sheet, sample-batch information, quality agreement, batch traceability and change-control process. Each document answers a different question. One document cannot replace all the others.
For more on supplier quality and traceability, see quality documentation and batch traceability support. You can also read what to check in pharmaceutical empty capsule quality control.
How StellarCaps supports pharmaceutical capsule projects
Jilin Xingyuan Capsule Co., Ltd. (StellarCaps) is an empty capsule manufacturer based in Huinan Economic Development Zone, Tonghua, Jilin Province, China. The company serves pharmaceutical, nutraceutical, dietary supplement and OEM/ODM customers. Its product range includes gelatin empty capsules, HPMC empty capsules, pullulan capsules and hydroxypropyl starch capsules.
StellarCaps can support common capsule sizes such as 00, 0, 1, 2, 3 and 4, along with color, printing, sample testing, quality documents, batch traceability and bulk supply planning.
If your team is reviewing pharmaceutical HPMC capsules, gelatin empty capsules or China CDE status A records, you can contact StellarCaps to request samples, quality documents or a bulk quote.
Frequently Asked Questions
What should buyers check in an empty capsule CDE record?
Check the product name, CDE registration number, registration status and registration holder. For pharmaceutical projects, status A and a matching supplier identity are especially important.
Is a CDE number enough for HPMC empty capsules?
No. Buyers should also check whether the status is A, whether the product name matches HPMC empty capsules, and whether the supplier can provide COA documents, specifications and samples for testing.
What should buyers review after confirming CDE status A?
Buyers should continue with COA documents, specifications, sample-batch information, packaging details, storage conditions and batch traceability. The CDE record helps with early screening, but the final choice still depends on the product and the project.
Which StellarCaps products have CDE status A?
StellarCaps gelatin empty capsules have registration number F20240000553 and status A. StellarCaps HPMC empty capsules, registered as hydroxypropyl methylcellulose empty capsules, have registration number F20240000554 and status A.